[Application of systemic enzyme therapy in combined treatment of patients with pulmonary cancer and malignant thymoma].
The systemic enzymotherapy using Wobe-Mugos E in the combined treatment of 32 patients with pulmonary cancer and of 21 patients with malignant thymoma was applied. After the chemotherapy and radiotherapy conduction the reduction of the postoperative septic-purulent complications, the pneumofibrosis occurrence prophylaxis was noted.
Hanul
V L
VL
Smolanka
I I
II
Ponomar'ova
O V
OV
D000276:Adjuvants, Immunologic / Q000008:administration & dosage / Q000627:therapeutic use*; D002918:Chymotrypsin; D003131:Combined Modality Therapy; D004338:Drug Combinations; D006801:Humans; D008175:Lung Neoplasms / Q000150:complications / Q000628:therapy*; D010184:Pancreatic Extracts / Q000008:administration & dosage / Q000627:therapeutic use*; D010206:Papain / Q000008:administration & dosage / Q000627:therapeutic use*; D013945:Thymoma / Q000150:complications / Q000628:therapy*; D013949:Thymus Extracts / Q000008:administration & dosage / Q000627:therapeutic use*; D013953:Thymus Neoplasms / Q000150:complications / Q000628:therapy*; D014357:Trypsin
D000276:Adjuvants, Immunologic; D004338:Drug Combinations; D010184:Pancreatic Extracts; D013949:Thymus Extracts; C009685:chymotrypsin, papain, trypsin drug combination; D002918:Chymotrypsin; D014357:Trypsin; D010206:Papain